High-throughput quantitative bioluminescence imaging for assessing tumor burden.
Bioluminescence imaging (BLI) has emerged during the past 5 years as the preeminent method for rapid, cheap, facile screening of tumor growth and spread in mice. Both subcutaneous and orthotopic tumor models are readily observed with high sensitivity and reproducibility. User-friendly commercial instruments exist and, increasingly, luciferase-expressing tumor cells are available in academic institutions or commercially. There is an increasing literature on routine use of BLI for assessing chemotherapeutic efficacy, drug combinations, dosing, and timing. In addition, BLI may be applied to more sophisticated questions of molecular biology by including specific promoter sequences. This chapter will describe routine methods used to support multiple investigators in our small animal imaging resource.
Contero
Angelina
A
Cancer Imaging Program, UT Southwestern, Dallas, TX, USA.
Richer
Edmond
E
Gondim
Ana
A
Mason
Ralph P
RP
D000818:Animals; D006367:HeLa Cells; D006801:Humans; D049449:Luminescence; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000473:pathology*; D015203:Reproducibility of Results
Mol Imaging. 2004 Apr;3(2):117-24
15296676
Genes Dev. 2003 Mar 1;17(5):545-80
12629038
Mol Imaging. 2007 Jul-Aug;6(4):219-28
17711777
J Magn Reson Imaging. 2002 Oct;16(4):378-87
12353253
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):377-82
11752410
J Surg Res. 2004 Aug;120(2):249-55
15234220
Int J Cancer. 2007 Apr 15;120(8):1795-802
17230511
Methods Enzymol. 2000;305:346-70
10812612
J Cancer Res Clin Oncol. 1993;119(10):599-608
8335679
Cancer Biol Ther. 2003 Mar-Apr;2(2):196-202
12750563
Biotechniques. 2007 Jul;43(1 Suppl):7-13, 30
17936938